{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T14:13:40Z","timestamp":1772115220908,"version":"3.50.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1007\/s11060-013-1287-z","type":"journal-article","created":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T02:44:10Z","timestamp":1383273850000},"page":"267-274","source":"Crossref","is-referenced-by-count":15,"title":["Study of chromosome 9q gain, Notch pathway regulators and Tenascin-C in ependymomas"],"prefix":"10.1007","volume":"116","author":[{"given":"Rakesh Kumar","family":"Gupta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehar C.","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vaishali","family":"Suri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aanchal","family":"Kakkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manmohan","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chitra","family":"Sarkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,11,1]]},"reference":[{"key":"1287_CR1","first-page":"79","volume-title":"WHO classification of tumours of the central nervous system","author":"RE McLendon","year":"2007","unstructured":"McLendon RE, Wiestler OD, Kros JM, Korshunov A, Ng HK (2007) Anaplastic ependymoma. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (eds) WHO classification of tumours of the central nervous system, vol 4. IARC Press, Lyon, pp 79\u201380"},{"key":"1287_CR2","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/(SICI)1096-911X(199806)30:6<319::AID-MPO1>3.0.CO;2-H","volume":"30","author":"E Bouffet","year":"1998","unstructured":"Bouffet E, Perilongo G, Canete A, Massimino M (1998) Intracranial ependymomas in children: a critical review of prognostic factors and a plea for cooperation. Med Pediatr Oncol 30:319\u2013331","journal-title":"Med Pediatr Oncol"},{"key":"1287_CR3","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/1097-0142(19950101)75:1+<395::AID-CNCR2820751321>3.0.CO;2-W","volume":"75","author":"RW Miller","year":"1995","unstructured":"Miller RW, Young JL Jr, Novakovic B (1995) Childhood cancer. Cancer 75:395\u2013405","journal-title":"Cancer"},{"key":"1287_CR4","first-page":"629","volume":"16","author":"TE Merchant","year":"2002","unstructured":"Merchant TE (2002) Current management of childhood ependymoma. Oncology (Williston Park) 16:629\u2013648","journal-title":"Oncology (Williston Park)"},{"key":"1287_CR5","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.jss.2009.04.024","volume":"156","author":"D Rodr\u00edguez","year":"2009","unstructured":"Rodr\u00edguez D, Cheung MC, Housri N, Quinones-Hinojosa A, Camphausen K, Koniaris LG (2009) Outcomes of malignant CNS ependymomas: an examination of 2408 cases through the Surveillance, Epidemiology, and End Results (SEER) database (1973\u20132005). J Surg Res 156:340\u2013351","journal-title":"J Surg Res"},{"key":"1287_CR6","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/j.ejca.2009.03.018","volume":"45","author":"B Messahel","year":"2009","unstructured":"Messahel B, Ashley S, Saran F, Ellison D, Ironside J, Phipps K, Cox T, Chong WK, Robinson K, Picton S, Pinkerton CR, Mallucci C, Macarthur D, Jaspan T, Michalski A, Grundy RG, Children\u2019s Cancer Leukaemia Group Brain Tumour Committee (2009) Relapsed intracranial ependymoma in children in the UK: patterns of relapse, survival and therapeutic outcome. Eur J Cancer 45:1815\u20131823","journal-title":"Eur J Cancer"},{"key":"1287_CR7","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3171\/jns.2000.93.4.0605","volume":"93","author":"D Figarella-Branger","year":"2000","unstructured":"Figarella-Branger D, Civatte M, Bouvier-Labit C, Gouvernet J, Gambarelli D, Gentet JC, Lena G, Choux M, Pellissier JF (2000) Prognostic factors in intracranial ependymomas in children. J Neurosurg 93:605\u2013613","journal-title":"J Neurosurg"},{"key":"1287_CR8","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1002\/cncr.20075","volume":"100","author":"A Korshunov","year":"2004","unstructured":"Korshunov A, Golanov A, Sycheva R, Timirgaz V (2004) The histologic grade is a main prognostic factor for patients with intracranial ependymomas treated in the microneurosurgical era: an analysis of 258 patients. Cancer 100:1230\u20131237","journal-title":"Cancer"},{"key":"1287_CR9","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/cncr.21608","volume":"106","author":"E Kurt","year":"2006","unstructured":"Kurt E, Zheng PP, Hop WC, van der Weiden M, Bol M, van den Bent MJ, Avezaat CJ, Kros JM (2006) Identification of relevant prognostic histopathologic features in 69 intracranial ependymomas, excluding myxopapillary ependymomas and subependymomas. Cancer 106:388\u2013395","journal-title":"Cancer"},{"key":"1287_CR10","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000028654","volume":"28","author":"PK Duffner","year":"1998","unstructured":"Duffner PK, Krischer JP, Sanford RA, Horowitz ME, Burger PC, Cohen ME, Friedman HS, Kun LE (1998) Prognostic factors in infants and very young children with intracranial ependymomas. Pediatr Neurosurg 28:215\u2013222","journal-title":"Pediatr Neurosurg"},{"key":"1287_CR11","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1200\/JCO.2001.19.5.1288","volume":"19","author":"J Grill","year":"2000","unstructured":"Grill J, Le Deley MC, Gambarelli D, Raquin MA, Couanet D, Pierre-Kahn A, Habrand JL, Doz F, Frappaz D, Gentet JC, Edan C, Chastagner P, Kalifa C, French Society of Pediatric Oncology (2000) Postoperative chemotherapy without irradiation for ependymoma in children under 5\u00a0years of age: a multicenter trial of the French Society of Pediatric Oncology. J Clin Oncol 19:1288\u20131296","journal-title":"J Clin Oncol"},{"key":"1287_CR12","volume-title":"Tumors of the central nervous system","author":"RLPR Heidemann","year":"1997","unstructured":"Heidemann RLPR, Albright LA, Freeman CR, Rorke LB (1997) Tumors of the central nervous system, 1st edn. Lippincott-Raven, Philadelphia","edition":"1"},{"key":"1287_CR13","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/S1470-2045(07)70208-5","volume":"8","author":"RG Grundy","year":"2007","unstructured":"Grundy RG, Wilne SA, Weston CL, Robinson K, Lashford LS, Ironside J, Cox T, Chong WK, Campbell RH, Bailey CC, Gattamaneni R, Picton S, Thorpe N, Mallucci C, English MW, Punt JA, Walker DA, Ellison DW, Machin D, Children\u2019s Cancer and Leukaemia Group (formerly UKCCSG) Brain Tumour Committee (2007) Primary postoperative chemotherapy without radiotherapy for intracranial ependymoma in children: the UKCCSG\/SIOP prospective study. Lancet Oncol 8:696\u2013705","journal-title":"Lancet Oncol"},{"key":"1287_CR14","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1111\/j.1750-3639.1997.tb01066.x","volume":"7","author":"RL Hamilton","year":"1997","unstructured":"Hamilton RL, Pollack IF (1997) The molecular biology of ependymomas. Brain Pathol 7:807\u2013822","journal-title":"Brain Pathol"},{"key":"1287_CR15","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1593\/neo.05715","volume":"8","author":"U Tabori","year":"2006","unstructured":"Tabori U, Vukovic B, Zielenska M, Hawkins C, Braude I, Rutka J, Bouffet E, Squire J, Malkin D (2006) The role of telomere maintenance in the spontaneous growth arrest of pediatric low-grade gliomas. Neoplasia 8:136\u2013142","journal-title":"Neoplasia"},{"issue":"2","key":"1287_CR16","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/neuonc\/nop022","volume":"12","author":"MT Stockhausen","year":"2010","unstructured":"Stockhausen MT, Kristoffersen K, Poulsen HS (2010) The functional role of Notch signaling in human gliomas. Neuro Oncol 12(2):199\u2013211","journal-title":"Neuro Oncol"},{"issue":"31","key":"1287_CR17","doi-asserted-by":"crossref","first-page":"3454","DOI":"10.1038\/onc.2011.58","volume":"30","author":"M Ying","year":"2011","unstructured":"Ying M, Wang S, Sang Y, Sun P, Lal B, Goodwin CR, Guerrero-Cazares H, Quinones-Hinojosa A, Laterra J, Xia S (2011) Regulation of glioblastoma stem cells by retinoic acid: role for Notch pathway inhibition. Oncogene 30(31):3454\u20133467","journal-title":"Oncogene"},{"issue":"21","key":"1287_CR18","doi-asserted-by":"crossref","first-page":"7787","DOI":"10.1158\/0008-5472.CAN-04-1446","volume":"64","author":"X Fan","year":"2004","unstructured":"Fan X, Mikolaenko I, Elhassan I, Ni X, Wang Y, Ball D, Brat DJ, Perry A, Eberhart CG (2004) Notch1 and notch2 have opposite effects on embryonal brain tumor growth. Cancer Res 64(21):7787\u20137793","journal-title":"Cancer Res"},{"issue":"21","key":"1287_CR19","doi-asserted-by":"crossref","first-page":"7794","DOI":"10.1158\/0008-5472.CAN-04-1813","volume":"64","author":"AR Hallahan","year":"2004","unstructured":"Hallahan AR, Pritchard JI, Hansen S, Benson M, Stoeck J, Hatton BA, Russell TL, Ellenbogen RG, Bernstein ID, Beachy PA, Olson JM (2004) The SmoA1 mouse model reveals that notch signaling is critical for the growth and survival of sonic hedgehog-induced medulloblastomas. Cancer Res 64(21):7794\u20137800","journal-title":"Cancer Res"},{"key":"1287_CR20","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/(SICI)1098-2264(199903)24:3<230::AID-GCC8>3.0.CO;2-C","volume":"24","author":"DA Reardon","year":"1999","unstructured":"Reardon DA, Entrekin RE, Sublett J, Ragsdale S, Li H, Boyett J, Kepner JL, Look AT (1999) Chromosome arm 6q loss is the most common recurrent autosomal alteration detected in primary pediatric ependymoma. Genes Chromosomes Cancer 24:230\u2013237","journal-title":"Genes Chromosomes Cancer"},{"key":"1287_CR21","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/S0002-9440(10)64061-8","volume":"158","author":"Y Hirose","year":"2001","unstructured":"Hirose Y, Aldape K, Bollen A et al (2001) Chromosomal abnormalities subdivide ependymal tumors into clinically relevant groups. Am J Pathol 158:1137\u20131143","journal-title":"Am J Pathol"},{"issue":"86","key":"1287_CR22","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/sj.bjc.6600180","volume":"18","author":"M Carter","year":"2002","unstructured":"Carter M, Nicholson J, Ross F, Crolla J, Allibone R, Balaji V, Perry R, Walker D, Gilbertson R, Ellison DW (2002) Genetic abnormalities detected in ependymomas by comparative genomic hybridisation. Br J Cancer 18(86):929\u2013939","journal-title":"Br J Cancer"},{"key":"1287_CR23","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/S0002-9440(10)64491-4","volume":"161","author":"S Dyer","year":"2002","unstructured":"Dyer S, Prebble E, Davison V, Davies P, Ramani P, Ellison D, Grundy R (2002) Genomic imbalances in pediatric intracranial ependymomas define clinically relevant groups. Am J Pathol 161:2133\u20132141","journal-title":"Am J Pathol"},{"key":"1287_CR24","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/path.1086","volume":"197","author":"JW Jeuken","year":"2002","unstructured":"Jeuken JW, Sprenger SH, Gilhuis J, Teepen HL, Grotenhuis AJ, Wesseling P (2002) Correlation between localization, age, and chromosomal imbalances in ependymal tumours as detected by CGH. J Pathol 197:238\u2013244","journal-title":"J Pathol"},{"key":"1287_CR25","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1158\/1078-0432.CCR-05-2363","volume":"12","author":"F Mendrzyk","year":"2006","unstructured":"Mendrzyk F, Korshunov A, Benner A, Toedt G, Pfister S, Radlwimmer B, Lichter P (2006) Identification of gains on 1q and epidermal growth factor receptor overexpression as independent prognostic markers in intracranial ependymoma. Clin Cancer Res 12:2070\u20132079","journal-title":"Clin Cancer Res"},{"issue":"261","key":"1287_CR26","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.canlet.2007.11.021","volume":"18","author":"A Pezzolo","year":"2008","unstructured":"Pezzolo A, Capra V, Raso A, Morandi F, Parodi F, Gambini C, Nozza P, Giangaspero F, Cama A, Pistoia V, Garr\u00e8 ML (2008) Identification of novel chromosomal abnormalities and prognostic cytogenetics markers in intracranial pediatric ependymoma. Cancer Lett 18(261):235\u2013243","journal-title":"Cancer Lett"},{"key":"1287_CR27","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/gcc.20207","volume":"43","author":"AC Ammerlaan","year":"2005","unstructured":"Ammerlaan AC, de Bustos C, Ararou A, Buckley PG, Mantripragada KK, Verstegen MJ, Hulsebos TJ, Dumanski JP (2005) Localization of a putative low-penetrance ependymoma susceptibility locus to 22q11 using a chromosome 22 tiling-path genomic microarray. Genes Chromosomes Cancer 43:329\u2013338","journal-title":"Genes Chromosomes Cancer"},{"key":"1287_CR28","doi-asserted-by":"crossref","first-page":"5223","DOI":"10.1200\/JCO.2006.06.3701","volume":"24","author":"P Modena","year":"2006","unstructured":"Modena P, Lualdi E, Facchinetti F et al (2006) Identification of tumor-specific molecular signatures in intracranial ependymoma and association with clinical characteristics. J Clin Oncol 24:5223\u20135233","journal-title":"J Clin Oncol"},{"key":"1287_CR29","doi-asserted-by":"crossref","first-page":"3955","DOI":"10.1002\/cncr.24476","volume":"115","author":"T Palm","year":"2009","unstructured":"Palm T, Figarella-Branger D, Chapon F, Lacroix C, Gray F, Scaravilli F, Ellison DW, Salmon I, Vikkula M, Godfraind C (2009) Expression profiling of ependymomas unravels localization and tumor grade-specific tumorigenesis. Cancer 115:3955\u20133968","journal-title":"Cancer"},{"key":"1287_CR30","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1200\/JCO.2007.15.4195","volume":"27","author":"S Puget","year":"2009","unstructured":"Puget S, Grill J, Valent A, Bieche I, Dantas-Barbosa C, Kauffmann A, Dessen P, Lacroix L, Geoerger B, Job B, Dirven C, Varlet P, Peyre M, Dirks PB, Sainte-Rose C, Vassal G (2009) Candidate genes on chromosome 9q33-34 involved in the progression of childhood ependymomas. J Clin Oncol 27:1884\u20131892","journal-title":"J Clin Oncol"},{"key":"1287_CR31","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s11060-009-0039-6","volume":"97","author":"A Rousseau","year":"2010","unstructured":"Rousseau A, Idbaih A, Ducray F, Crini\u00e8re E, F\u00e8vre-Montange M, Jouvet A, Delattre JY (2010) Specific chromosomal imbalances as detected by array CGH in ependymomas in association with tumor location, histological subtype and grade. J Neurooncol 97:353\u2013364","journal-title":"J Neurooncol"},{"key":"1287_CR32","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1200\/JCO.2009.27.3359","volume":"28","author":"A Korshunov","year":"2010","unstructured":"Korshunov A, Witt H, Hielscher T, Benner A, Remke M, Ryzhova M, Milde T, Bender S, Wittmann A, Sch\u00f6ttler A, Kulozik AE, Witt O, von Deimling A, Lichter P, Pfister S (2010) Molecular staging of intracranial ependymoma in children and adults. J Clin Oncol 28:3182\u20133190","journal-title":"J Clin Oncol"},{"key":"1287_CR33","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1093\/jnen\/62.9.927","volume":"62","author":"MB Mahler-Araujo","year":"2003","unstructured":"Mahler-Araujo MB, Sanoudou D, Tingby O, Liu L, Coleman N, Ichimura K, Collins VP (2003) Structural genomic abnormalities of chromosomes 9 and 18 in myxopapillary ependymomas. J Neuropathol Exp Neurol 62:927\u2013935","journal-title":"J Neuropathol Exp Neurol"},{"key":"1287_CR34","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1158\/1541-7786.MCR-08-0584","volume":"7","author":"JP Kilday","year":"2009","unstructured":"Kilday JP, Rahman R, Dyer S, Ridley L, Lowe J, Coyle B, Grundy R (2009) Pediatric ependymoma: biological perspectives. Mol Cancer Res 7:765\u2013786","journal-title":"Mol Cancer Res"},{"key":"1287_CR35","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1750-3639.2001.tb00386.x","volume":"11","author":"S Scheil","year":"2001","unstructured":"Scheil S, Bruderlein S, Eicker M, Herms J, Herold-Mende C, Steiner HH, Barth TF, Moller P (2001) Low frequency of chromosomal imbalances in anaplastic ependymomas as detected by comparative genomic hybridization. Brain Pathol 11:133\u2013143","journal-title":"Brain Pathol"},{"key":"1287_CR36","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.ccr.2005.09.001","volume":"8","author":"MD Taylor","year":"2005","unstructured":"Taylor MD, Poppleton H, Fuller C et al (2005) Radial glia cells are candidate stem cells of ependymoma. Cancer Cell 8:323\u2013335","journal-title":"Cancer Cell"},{"issue":"98","key":"1287_CR37","first-page":"362","volume":"20","author":"C Herold-Mende","year":"2000","unstructured":"Herold-Mende C, Mueller MM, Bonsanto MM, Schmitt HP, Kunze S, Steiner HH (2000) Clinical impact and functional aspects of tenascin-C expression during glioma progression. Int J Cancer 20(98):362\u2013369","journal-title":"Int J Cancer"},{"key":"1287_CR38","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1023\/A:1016222202230","volume":"58","author":"A Korshunov","year":"2000","unstructured":"Korshunov A, Golanov A, Timirgaz V (2000) Immunohistochemical markers for prognosis of ependymal neoplasms. J Neurooncol 58:255\u2013270","journal-title":"J Neurooncol"},{"key":"1287_CR39","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nrc1592","volume":"5","author":"BJ Huntly","year":"2005","unstructured":"Huntly BJ, Gilliland DG (2005) Leukaemia stem cells and the evolution of cancer-stem-cell research. Nat Rev Cancer 5:311\u2013321","journal-title":"Nat Rev Cancer"},{"key":"1287_CR40","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1200\/JCO.2005.03.4082","volume":"24","author":"DA Reardon","year":"2006","unstructured":"Reardon DA, Akabani G, Coleman RE et al (2006) Salvage radioimmunotherapy with murine iodine-131-labeled antitenascin monoclonal antibody 81C6 for patients with recurrent primary and metastatic malignant brain tumors: phase II study results. J Clin Oncol 24:115\u2013122","journal-title":"J Clin Oncol"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-013-1287-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-013-1287-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-013-1287-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,31]],"date-time":"2019-07-31T17:34:14Z","timestamp":1564594454000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-013-1287-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,1]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["1287"],"URL":"https:\/\/doi.org\/10.1007\/s11060-013-1287-z","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,1]]}}}